UK Today News, November 12, 2021
Ground-breaking research from Heriot-Watt University and the University of Texas Medical Branch is set to be commercialized following a funding award from Scottish Enterprise’s High Growth Spinout Programme. The new research has identified a way of targeting an enzyme called EPAC1, which is involved in the inflammation process and is responsible for many of the most serious yet common chronic diseases.